These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1195 related articles for article (PubMed ID: 33154422)

  • 1. Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments.
    Vagima Y; Gur D; Erez N; Achdout H; Aftalion M; Levy Y; Zauberman A; Tidhar A; Gutman H; Lazar S; Israely T; Paran N; Melamed S; Brosh-Nissimov T; Chitlaru T; Sagi I; Mamroud E
    Sci Rep; 2020 Nov; 10(1):19116. PubMed ID: 33154422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
    Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
    J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
    Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.
    Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E
    PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Neutrophil Primary Granule Release during Yersinia pestis Pulmonary Infection.
    Eichelberger KR; Jones GS; Goldman WE
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel post-exposure medical countermeasure L-97-1 improves survival and acute lung injury following intratracheal infection with Yersinia pestis.
    Wilson CN; Vance CO; Doyle TM; Brink DS; Matuschak GM; Lechner AJ
    Innate Immun; 2012 Jun; 18(3):373-89. PubMed ID: 21862597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of UDP-glucose pyrophosphorylase from Yersinia pestis, a potential therapeutic target against plague.
    Gibbs ME; Lountos GT; Gumpena R; Waugh DS
    Acta Crystallogr F Struct Biol Commun; 2019 Sep; 75(Pt 9):608-615. PubMed ID: 31475928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].
    Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV
    Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulence.
    Eddy JL; Schroeder JA; Zimbler DL; Caulfield AJ; Lathem WW
    J Thromb Haemost; 2016 Sep; 14(9):1833-43. PubMed ID: 27377187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with Fluticasone Propionate Increases Antibiotic Efficacy during Treatment of Late-Stage Primary Pneumonic Plague.
    Crane SD; Banerjee SK; Pechous RD
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0127521. PubMed ID: 34780267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
    Bonacorsi SP; Scavizzi MR; Guiyoule A; Amouroux JH; Carniel E
    Antimicrob Agents Chemother; 1994 Mar; 38(3):481-6. PubMed ID: 8203841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of Neutrophil Recruitment to Mice Lungs During Pneumonic Plague.
    Vagima Y; Levy Y; Mamroud E
    Methods Mol Biol; 2019; 2010():141-150. PubMed ID: 31177436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of monoclonal antibodies to plague microbe antigens at the early stage of infection in white mice for enhancement of the late streptomycin and doxycycline treatment].
    Ryzhko IV; Tsuraeva RI; Alekseeva LP; Shcherbaniuk AI; Mishan'kin MB
    Antibiot Khimioter; 2003; 48(3):21-5. PubMed ID: 12914117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylactic use of ceftriaxone in combination with F I antigen immunization in studies on uninbred albino mice infected by Yersinia pestis. Antiplague immunity development].
    Ryzhko IV; Moldavan IA; Tsuraeva RI; Shcherbaniuk AI
    Antibiot Khimioter; 2006; 51(9-10):8-12. PubMed ID: 18030785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.